Sign up for the QMED & MD+DI Daily newsletter.
Machiel Van Der Leest
November 1, 2008
2 Min Read
Bioresorbable stent company Arterial Remodeling Technologies (ART; Paris) has appointed Machiel Van Der Leest as its new CEO. Van Der Leest has served as ART's chief operating officer since March 2008. Prior to joining ART, he was director of R&D and regulatory affairs at Minvasys. "The timing of Machiel's appointment as CEO signals a major turning point in the evolution of ART, from an R&D mind-set to a product-development mandate," said ART chairman Eric Viaud.
Vapotherm (Stevensville, MD), a privately held manufacturer of respiratory care devices for the hospital and home-care markets, has announced the appointment of industry veteran Nick Macmillan as manager of its home-care segment. Macmillan will be responsible for developing and managing the company's expansion of respiratory therapy products that address chronic and sleep disorders. Vapotherm is focused on the development of noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders.
MedPro Safety Products Inc. (Lexington, KY), a developer and marketer of medical safety devices incorporating proprietary needlestick prevention technology, has appointed two new members to its board of directors: Leo Kiely, CEO of MillerCoors; and Ernest L. Fletcher, MD, former governor of Kentucky. "We are fortunate to have such talented and experienced individuals joining our board," said MedPro CEO Craig Turner. "Both Mr. Kiely and Governor Fletcher have extensive expertise in their respective fields and will play an integral role in the continued growth of our company."
Copyright ©2008 MX
You May Also Like
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read
Top 40 Medical Device CompaniesFeb 29, 2024|2 Min Read
2024 Planning Guide for Medical Manufacturing AutomationFeb 29, 2024|1 Min Read
Adverse Events Reported for Hologic BioZorb Marker, BioZorb LP MarkerFeb 28, 2024|2 Min Read